This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Utah Medical Products, Inc. Reports Financial Performance For Third Quarter 2010

SALT LAKE CITY, Oct. 21, 2010 (GLOBE NEWSWIRE) -- Utah Medical Products, Inc. (Nasdaq:UTMD) reports lower sales, improved profit margins and a stronger ending balance sheet for the third calendar quarter (3Q) 2010 compared to 3Q 2009.

Despite lower total sales for the third quarter, domestic sales have improved in 2010 on a quarterly basis:  

(in thousand $) 1Q 2010 (JAN – MAR) 2Q 2010 (APR – JUN) 3Q 2010 (JUL – SEP)
Domestic Direct: 4,040 4,035 4,094
Domestic OEM:  335  359  361
Domestic Total: 4,375 4,394 4,455

Continued lower U.S. hospital utilization rates of medical devices and unit price reductions have resulted in three quarters year-to-date, or nine months (9M) of 2010, domestic sales that were 5% lower than in 9M 2009.

International sales in 2010, on the other hand, have declined on a quarterly basis:

(in thousand $) 1Q 2010 (JAN – MAR) 2Q 2010 (APR – JUN) 3Q 2010 (JUL – SEP)
International: 2,060 1,882 1,745

However, 9M 2010 international sales were 5% higher than in 9M 2009. International sales fluctuate because UTMD sells through third party distributors which purchase several months' of supply at a time to minimize costs. UTMD expects that 4Q 2010 international sales will recover closer to 1Q 2010. 

Profit margins in 3Q 2010 improved compared to 3Q 2009:

    3Q 2010 (JUL – SEP) 3Q 2009 (JUL – SEP)
Gross Profit Margin (gross profits/ sales): 53.8% 52.4%
Operating Profit Margin (operating profits/ sales): 36.4% 35.7%
Net Profit Margin (profit after taxes/ sales): 24.4% 24.2%

Although the unit prices of devices sold declined, UTMD achieved a higher 3Q 2010 gross profit margin (GPM) due to three factors: 1) a more favorable distribution mix as international sales at lower prices were a smaller portion of total sales, 2) lower manufacturing overhead costs as a result of the completion of consolidating Oregon molding operations into Utah in 2Q 2010, and 3) reallocation of shipping costs previously included in cost of goods sold to operating expenses (sales and marketing expense).

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs